Market Analysis

May 2014

Cardiac Rhythm Management Devices | China | 2014 | Market Analysis

Introduction:

The Chinese market for CRM devices will experience robust growth through 2022, driven primarily by rising use of this technology to treat arrhythmia and heart failure.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM devices in China across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   The use of CRM is growing rapidly in China.

How fast are CRM device implantations growing, and for what indications are they being used?

What factors are driving treatment volume growth?

How will the growing use of CRM devices in treating heart failure change device use and competitors' strategies?

  *   Domestic competitors are almost nonexistent in the Chinese CRM market.

Who are the major competitors in the Chinese CRM market?

Why have domestic manufacturers not made progress in competing with multinationals?

Which companies are planning to enter the CRM market over the forecast period?

  *   The Chinese CRM device market is characterized by large regional disparities.

Where are the largest regional markets currently?

Where are the fastest-growing regional markets?

What cities and hospitals perform the procedures?

Scope:

Geographies Covered: Millennium Research Group's analysis uses the following breakdown of regions in China:

Country

China

Region

PLMs

East Coast

Central

Other Regions

Notes: PLMs include Beijing, Shanghai, and Tianjin. East coast includes Fujian, Guangdong, Jiangsu, Shandong, and Zhejiang. Central includes Anhui, Hebei, Henan, Hubei, Hunan, Jiangxi, and Shanxi. Other regions include Chongqing, Gansu, Guangxi, Guizhou, Hainan, Heilongjiang, Inner Mongolia, Jilin, Liaoning, Ningxia, Qinghai, Shaanxi, Sichuan, Tibet, Xinjiang, and Yunnan.

Procedures Covered: Millennium Research Group's analysis uses the following breakdown of procedures:

Product Type

Pacemakers

Procedure Type

Initial Implant

Replacement

Upgrade

ICDs

Procedure Type

Initial Implant

Replacement

Upgrade

CRT Devices

Procedure Type

Initial Implant

Replacement

Upgrade

Products Covered: Millennium Research Group's analysis uses the following breakdown of products in the market:

Product Type

Pacemakers

Component

Pulse Generators

Product Type

Single-Chamber

Product Type

Traditional

Leadless

Dual-Chamber

Pacemaker Leads

ICDs

Component

Pulse Generators

Product Type

Single-Chamber

Product Type

Traditional

S-ICD

Dual-Chamber

Pacemaker Leads

ICD Leads

CRT Devices

Component

Pulse Generators

Product Type

CRT-Ps

CRT-Ds

Pacemaker Leads

ICD Leads

LV Leads

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Darren Lin

Contributors
April Chan
Samuli Heilala, M.Sc.
Veronica Ross
Kathleen Zorzella



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • BIOTRONIK
  • Boston Scientific
  • Lepu Medical Technology (Beijing)
  • Medtronic
  • MicroPort Medical
  • Sorin Group
  • St. Jude Medical
  • Vitatron
Decision Resources Group brands include: